The history of the drug-induced enterocolitis syndrome.
drug-induced enterocolitis syndrome
food protein-induced enterocolitis syndrome
history
pediatrics
rare allergic diseases
Journal
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
28
07
2021
received:
11
06
2021
accepted:
06
08
2021
entrez:
26
1
2022
pubmed:
27
1
2022
medline:
1
4
2022
Statut:
ppublish
Résumé
The diagnosis of drug-induced enterocolitis syndrome (DIES), resembling the typical findings of a well-known disease, the food protein-induced enterocolitis syndrome (FPIES), was acknowledged in the first publication on the topic in 2014. Ten cases of DIES have been described so far. Unanswered questions concerning DIES include its pathogenetic mechanism, natural history, the possible presence of predisposing genetic factors, and the potential existence of its atypical forms. DIES is a recently defined and intriguing clinical entity, similar to FPIES but triggered by drugs. It seems well-defined from the clinical point of view, but its pathogenetic mechanisms are not known. DIES deserves more attention among allergists, especially among the professionals who work with children, and all efforts should be conceived to improve its correct recognition and accurate management.
Substances chimiques
Dietary Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
54-57Informations de copyright
© 2022 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Novembre E, Mori F, Barni S, et al. Drug-Induced Enterocolitis Syndrome (DIES). Pediatr Allergy Immunol. 2014;25:415-416.
Infante S, Zapatero L. Drug-induced enterocolitis syndrome by amoxicillin. Pediatr Allergy Immunol. 2017;28:105-106.
Van Thuijl AOJ, Landzaat LJ, Liem O, et al. Drug-induced enterocolitis syndrome (DIES). Ann Allergy, Asthma Immunol. 2019;122:538-539.
Worcel J, Tarelho M, Baron M, et al. Drug-induced enterocolitis syndrome (DIES) in a 10-year-old girl. Arch Pédiatrie. 2020;27:51-52.
Freundt Serpa N, Sánchez-Morillas L, Jaqueti Moreno P, et al. Drug-induced enterocolitis syndrome due to amoxicillin-clavulanic acid with good tolerance to penicillin. J Investig Allergol Clin Immunol. 2020;30:301-302.
García Rodríguez R, Alfaya Arias T, Borja Segade J, et al. Drug-induced enterocolitis in an adult patient. J Allergy Clin Immunol Pract. 2017;5:1752-1753.
Bouvette G, Verreault N, Gagnon N, et al. Drug-induced enterocolitis syndrome (DIES) with pantoprazole in an adult patient. J Allergy Clin Immunol Pract. 2020;8:3183-3184.
Mori F, Liccioli G, Fuchs O, et al. Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome. Pediatr Allergy Immunol. 2021;13491.
Mori F, Barni S, Saretta F, et al. Epidemiology of rare allergic diseases in children. Pediatr Allergy Immunol. 2020;31:39-42.
Lucena MI, Molokhia M, Shen Y, et al. Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles. Gastroenterology. 2011;141:338-347.